Orion Pharma (DHA:ORIONPHARM) Short-Term Capital Lease Obligation : BDT12 Mil (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Short-Term Capital Lease Obligation?

Orion Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was BDT12 Mil.

Orion Pharma's quarterly Short-Term Capital Lease Obligation declined from Mar. 2024 (BDT15 Mil) to Jun. 2024 (BDT14 Mil) and declined from Jun. 2024 (BDT14 Mil) to Sep. 2024 (BDT12 Mil).

Orion Pharma's annual Short-Term Capital Lease Obligation declined from Jun. 2022 (BDT32 Mil) to Jun. 2023 (BDT24 Mil) and declined from Jun. 2023 (BDT24 Mil) to Jun. 2024 (BDT14 Mil).

Orion Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Orion Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Short-Term Capital Lease Obligation Chart

Orion Pharma Annual Data

Trend

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

38.35

36.42

31.66

23.91

13.94

Orion Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															22.79	17.46	15.30	13.94	12.45

Orion Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Orion Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208

Website

https://www.orionpharmabd.com

Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines